Dr Agarwals Eye Hospital Ltd-$

BSE: 526783

10

total announcements

526783.BO · 15 min delayed

BSECompany Update▲ PositiveExpansion27 Aug 2026

Dr Agarwals Eye Hospital Ltd-$

Media Release - Launch of World''s first Pinhole Pupilloplasty (PPP) Centre by the Company, is submitted.

Dr Agarwals Eye Hospital Ltd has launched the World's First dedicated Pinhole Pupilloplasty (PPP) Centre at its flagship facility in Chennai, India. The centre will focus on delivering advanced clinical treatments using the Pinhole Pupilloplasty technique, developed by Dr. Amar Agarwal, to address complex corneal disorders.

Read more →📎 1 attachment
BSECompany UpdateResults15 Aug 2026

Dr Agarwals Eye Hospital Ltd-$

Newspaper Advertisement published for the 32nd Annual General Meeting is submitted.

Dr Agarwals Eye Hospital Ltd-$ has published a newspaper advertisement for the 32nd Annual General Meeting (AGM) of the company, which will be held on September 09, 2026. The notice includes details of the record date, e-voting instructions, and other necessary information for the AGM. The company has also made its annual report and other documents available on its website.

Read more →📎 1 attachment
BSEAGM/EGMResults14 Aug 2026

Dr Agarwals Eye Hospital Ltd-$

Notice convening the 32nd Annual General Meeting of the members of the Company which is scheduled to be held on September 09, 2026, is submitted.

Dr Agarwals Eye Hospital Ltd has announced its 32nd Annual General Meeting (AGM) to be held on September 09, 2026, through Video Conferencing (VC) / Other Audio Visual Means (OAVM. The AGM will consider and adopt the audited financial statement for the financial year ended March 31, 2026, and declare a final dividend of INR 4.00 per equity share (40%) for the financial year 2025-26.

Read more →📎 1 attachment
BSEOthersResults14 Aug 2026

Dr Agarwals Eye Hospital Ltd-$

Annual Report of Dr. Agarwal's Eye Hospital Limited for the financial year 2025-26 is submitted

Dr. Agarwal's Eye Hospital Ltd has submitted its annual report for the financial year 2025-26, along with the notice convening the 32nd Annual General Meeting (AGM) of the company. The report highlights the company's focus on clinical excellence, innovation, and expansion, including the adoption of Pinhole Pupilloplasty (PPP), a pioneering procedure in ophthalmology. The company has also emphasized its organic growth strategy and plans to expand its presence in Tamil Nadu and underserved markets.

Read more →📎 1 attachment